Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

De Meulemeester

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
Medical and Pediatric Oncology|November 1, 1996
Positional cloning of genes involved in the Beckwith-Wiedemann syndrome, hemihypertrophy, and associated childhood tumorsM Mannens, M Alders, B Redeker, et al.
Diabetologia|February 11, 2025
One-year real-world benefits of Tandem Control-IQ technology on glucose management and person-reported outcomes in adults with type 1 diabetes: a prospective observational cohort studyJolien De Meulemeester, Bart Keymeulen, Christophe De Block, et al.
Clinical Genetics|January 19, 2025
Unexpected High Prevalence of Focal Facial Dermal Dysplasia (FFDD) Type IV Is Linked to a Founder Effect in the Belgian PopulationAude Beyens, Stefanie Van De Voorde, Marta Guerreiro Santano Ramos Da Silva, et al.
Epilepsia|July 23, 2024
WONOEP appraisal: Modeling early onset epilepsiesAnn-Sofie De Meulemeester, Christopher Reid, Stéphane Auvin, et al.
The Journal of Clinical Endocrinology and Metabolism|May 7, 2025
Real-world Glycemic and Person-Reported Outcomes after Tandem Control-IQ initiation in Children with Type 1 DiabetesJolien De Meulemeester, Laura Valgaerts, Guy Massa, et al.
Diabetes, Obesity & Metabolism|October 27, 2025
One-year effectiveness and safety in young children aged 2-6 years with type 1 diabetes using an automated insulin delivery system: A real-world prospective cohort studyJolien De Meulemeester, Laura Valgaerts, Sylvie Tenoutasse, et al.
Journal of Neuropathology and Experimental Neurology|February 27, 2021
Hippocampal Sclerosis in Frontotemporal Dementia: When Vascular Pathology Meets NeurodegenerationAnne Sieben, Tim Van Langenhove, Yannick Vermeiren, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 2021
Randomised phase 2 study comparing the efficacy and safety of the oral tyrosine kinase inhibitor nintedanib with single agent ifosfamide in patients with advanced, inoperable, metastatic soft tissue sarcoma after failure of first-line chemotherapy: EORTC-1506-STBSG "ANITA"Patrick Schöffski, Maud Toulmonde, Anna Estival, et al.
Acta Orthopaedica|October 6, 2010
Incidence of low-grade infection in aseptic loosening of total hip arthroplastyDirk Jan F Moojen, Gijs van Hellemondt, H Charles Vogely, et al.
Diabetes Technology & Therapeutics|December 30, 2025
Cost-Utility Analysis of Control-IQ Technology Relative to Conventional Insulin Therapy in Adults with Type 1 DiabetesJolien De Meulemeester, Francesca Fiorentino, Nuno Picado, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
Medical and Pediatric Oncology|November 1, 1996
Positional cloning of genes involved in the Beckwith-Wiedemann syndrome, hemihypertrophy, and associated childhood tumorsM Mannens, M Alders, B Redeker, et al.
Diabetologia|February 11, 2025
One-year real-world benefits of Tandem Control-IQ technology on glucose management and person-reported outcomes in adults with type 1 diabetes: a prospective observational cohort studyJolien De Meulemeester, Bart Keymeulen, Christophe De Block, et al.
Clinical Genetics|January 19, 2025
Unexpected High Prevalence of Focal Facial Dermal Dysplasia (FFDD) Type IV Is Linked to a Founder Effect in the Belgian PopulationAude Beyens, Stefanie Van De Voorde, Marta Guerreiro Santano Ramos Da Silva, et al.
Epilepsia|July 23, 2024
WONOEP appraisal: Modeling early onset epilepsiesAnn-Sofie De Meulemeester, Christopher Reid, Stéphane Auvin, et al.
The Journal of Clinical Endocrinology and Metabolism|May 7, 2025
Real-world Glycemic and Person-Reported Outcomes after Tandem Control-IQ initiation in Children with Type 1 DiabetesJolien De Meulemeester, Laura Valgaerts, Guy Massa, et al.
Diabetes, Obesity & Metabolism|October 27, 2025
One-year effectiveness and safety in young children aged 2-6 years with type 1 diabetes using an automated insulin delivery system: A real-world prospective cohort studyJolien De Meulemeester, Laura Valgaerts, Sylvie Tenoutasse, et al.
Journal of Neuropathology and Experimental Neurology|February 27, 2021
Hippocampal Sclerosis in Frontotemporal Dementia: When Vascular Pathology Meets NeurodegenerationAnne Sieben, Tim Van Langenhove, Yannick Vermeiren, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 2021
Randomised phase 2 study comparing the efficacy and safety of the oral tyrosine kinase inhibitor nintedanib with single agent ifosfamide in patients with advanced, inoperable, metastatic soft tissue sarcoma after failure of first-line chemotherapy: EORTC-1506-STBSG "ANITA"Patrick Schöffski, Maud Toulmonde, Anna Estival, et al.
Acta Orthopaedica|October 6, 2010
Incidence of low-grade infection in aseptic loosening of total hip arthroplastyDirk Jan F Moojen, Gijs van Hellemondt, H Charles Vogely, et al.
Diabetes Technology & Therapeutics|December 30, 2025
Cost-Utility Analysis of Control-IQ Technology Relative to Conventional Insulin Therapy in Adults with Type 1 DiabetesJolien De Meulemeester, Francesca Fiorentino, Nuno Picado, et al.
Pageof 13